USFDA issues warning letter to Aurobindo Pharma's Telangana facility; stock dips 2 pc
New Delhi, Aug 14 (IANS) Shares of Aurobindo Pharma declined up to 2 per cent on Friday after the U.S. Food and Drug Administration (USFDA) issued a warning letter to a formulation manufacturing facility operated by its subsidiary -- Eugia Pharma Specialities Ltd -- in Telangana.